A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre

A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre

The increased use of immune checkpoint inhibitors across cancer programs has created the need for standardized patient assessment, education, monitoring, and management of immune-related adverse events (irAEs). At William Osler Health System in Brampton, Ontario, a practical step-wise approach detai...

Full description

Bibliographic Details
Main Authors: Parneet K. Cheema, Marco A. J. Iafolla, Massey Nematollahi, FeRevelyn Berco, Deepanjali Kaushik, Priscilla Matthews, William R. Raskin, Kirstin A. Perdrizet, Shaan Dudani, Juhi Husain, Margaret Balcewicz, Philip G. Kuruvilla, Stephen M. Reingold, Henry J. Conter
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Current Oncology
Subjects:
immune checkpoint inhibitors
immune-related adverse events
cancer immunotherapy
patient education
multidisciplinary teams
Online Access:https://www.mdpi.com/1718-7729/29/2/74

Internet

https://www.mdpi.com/1718-7729/29/2/74

Similar Items